GB1392094A - Aerosal bronchodilator compositions - Google Patents

Aerosal bronchodilator compositions

Info

Publication number
GB1392094A
GB1392094A GB3264572A GB3264572A GB1392094A GB 1392094 A GB1392094 A GB 1392094A GB 3264572 A GB3264572 A GB 3264572A GB 3264572 A GB3264572 A GB 3264572A GB 1392094 A GB1392094 A GB 1392094A
Authority
GB
United Kingdom
Prior art keywords
ethyl
bromide
ester
compositions
july
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3264572A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Boehringer Ingelheim GmbH
Original Assignee
CH Boehringer Sohn AG and Co KG
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG, Boehringer Ingelheim GmbH filed Critical CH Boehringer Sohn AG and Co KG
Publication of GB1392094A publication Critical patent/GB1392094A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB3264572A 1971-07-13 1972-07-12 Aerosal bronchodilator compositions Expired GB1392094A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2134899A DE2134899C3 (de) 1971-07-13 1971-07-13 Verwendung von N-Äthyl-norscopolaminmethobromid

Publications (1)

Publication Number Publication Date
GB1392094A true GB1392094A (en) 1975-04-23

Family

ID=5813500

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3264572A Expired GB1392094A (en) 1971-07-13 1972-07-12 Aerosal bronchodilator compositions

Country Status (13)

Country Link
US (1) US4016279A (https=)
AU (1) AU470025B2 (https=)
BE (1) BE786200A (https=)
CA (1) CA988418A (https=)
DE (1) DE2134899C3 (https=)
FR (1) FR2145693B1 (https=)
GB (1) GB1392094A (https=)
HK (1) HK49679A (https=)
IE (1) IE36952B1 (https=)
IL (1) IL39889A (https=)
IT (1) IT1116880B (https=)
NL (1) NL175493C (https=)
ZA (1) ZA724724B (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2214230C2 (ru) * 1998-06-19 2003-10-20 Ивэкс Рисёч, Инк. Аэрозольный препарат, адаптированный для использования в герметизированном аэрозольном контейнере
RU2684761C1 (ru) * 2018-02-20 2019-04-12 Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СибГМУ Минздрава России) Способ профилактики респираторных осложнений у пациентов после хирургического лечения рака легкого
RU2849281C1 (ru) * 2025-02-14 2025-10-23 Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ профилактики респираторных осложнений после торакальных операций

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183912A (en) * 1978-01-16 1980-01-15 American Home Products Corporation Inhalation therapy for relieving bronchial spasm using quaternary salts of promethazine
IT1164227B (it) * 1983-05-13 1987-04-08 Angeli Inst Spa Composizione farmaceutica atta alla somministrazione nasale di sali quaternari d'ammonio ed attivita' anticolinergica
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2753288A (en) * 1953-01-12 1956-07-03 Upjohn Co Scopolamine lower-alkyl halide therapeutic composition
US3169095A (en) * 1962-10-30 1965-02-09 Rexall Drug Chemical Self-propelling powder-dispensing compositions
DE1670048C3 (de) * 1966-01-26 1980-09-04 C.H. Boehringer Sohn, 6507 Ingelheim Neue Norscopolaminderivate

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2214230C2 (ru) * 1998-06-19 2003-10-20 Ивэкс Рисёч, Инк. Аэрозольный препарат, адаптированный для использования в герметизированном аэрозольном контейнере
RU2684761C1 (ru) * 2018-02-20 2019-04-12 Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СибГМУ Минздрава России) Способ профилактики респираторных осложнений у пациентов после хирургического лечения рака легкого
RU2849281C1 (ru) * 2025-02-14 2025-10-23 Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ профилактики респираторных осложнений после торакальных операций

Also Published As

Publication number Publication date
IL39889A (en) 1976-05-31
ZA724724B (en) 1974-03-27
AU4449872A (en) 1974-01-17
IE36952L (en) 1973-01-13
FR2145693B1 (https=) 1976-03-05
AU470025B2 (en) 1976-03-04
IL39889A0 (en) 1972-09-28
BE786200A (fr) 1973-01-12
NL175493B (nl) 1984-06-18
HK49679A (en) 1979-07-27
IT1116880B (it) 1986-02-10
NL7209675A (https=) 1973-01-16
CA988418A (en) 1976-05-04
IT7949433A0 (it) 1979-06-15
IE36952B1 (en) 1977-03-30
DE2134899A1 (de) 1973-02-01
DE2134899B2 (de) 1980-07-10
US4016279A (en) 1977-04-05
FR2145693A1 (https=) 1973-02-23
DE2134899C3 (de) 1981-04-02
NL175493C (nl) 1984-11-16

Similar Documents

Publication Publication Date Title
Cullum et al. Salbutamol: a new, selective β‐adrenoceptive receptor stimulant
AR042574A1 (es) Un metodo para modular la diabetes tipo 2 en un mamifero y una composicion farmaceutica que comprende derivados del acido (-) (-trihalometilfenoxi)(4-halofenil)acetico
PT73336A (en) Process for preparing carbamates of 1-(3,5-dihidroxiphenil)-2-butil terc.-amino)-ethanol with bronchial-spasmolitic activity and pharmaceutical compositions containing them
DE69104991D1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
GB1392094A (en) Aerosal bronchodilator compositions
Uragoda Tea maker's asthma
Perry et al. The mechanism of synergistic action of DMC with DDT against resistant house flies
Heathcote et al. Inhibition of the Growth of Leuconostoc mesenteroides by the Toxic Factor from ‘Agenized’Zein: Reversal by l-Glutamine
Terriere et al. The metabolism of naphthalene and 1-naphthol by houseflies and rats
JPS5569508A (en) Toothpaste composition
US3193373A (en) Method and composition for inhibiting tobacco suckers
US2259492A (en) Therapeutic preparation of bismuth and method of preparing same
GB1560463A (en) Heparin - based medicament adminstrable by the tracheo-bronchial and alveolar route
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
DE2245511A1 (de) Fungizides pflanzenpraeparat
GB1089043A (en) Aerosol compositions containing phenylephrine derivatives
GB1336230A (en) Insecticidal compositions containing chrysanthemates
US4039668A (en) Corticoid-containing inhalants
Ross et al. The effect of the introduction of amino acids into chicks infected with Salmonella pullorum
AT206895B (de) Verfahren zur Herstellung eines neuen Salzes des Piperazins mit 2,4,5-Trichlorphenol
US3208852A (en) Animal feed composition for prevention of mycotoxicoses and method for preparing same
Kasting et al. Amino Acid Requirements for the Wheat Stem Sawfly Determined with Glucose-U-C14 after Vacuum-infiltration1
JPS57136519A (en) Antidiabetic containing aminobenzoic acid derivative
DE2234227A1 (de) Pharmazeutische zubereitungen mit neuartiger therapeutischer wirkung
IL29370A (en) 1-phenyl-1-benzyl-2-methyl-3-dimethylaminopropanol esters with cardiovascular activity

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years